Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Severe Aberrant Behavior Among Persons With Mental Retardation. Project III: Behavioral Selectivity of Atypical Neuroleptic Drugs: Effects on Cognitive and Social Behaviors

NCT00065273 is registered in ClinicalTrials.gov with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) as lead sponsor.

NCT NCT00065273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00065273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Severe Aberrant Behavior Among Persons With Mental Retardation. Project III: Behavioral Selectivity of Atypical Neuroleptic Drugs: Effects on Cognitive and Social Behaviors
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase
Phase 3
Overall status
Completed
Start date
July 31, 1998
Completion date
June 30, 2001
Enrollment
50
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

developmental delay disorder, mental retardation